A Legacy Study in Participants With Gastrointestinal Stromal Tumors (GIST)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This study aims to evaluate the long-term safety and tolerability of velzatinib (GSK6042981) in adults with GIST who have previously received velzatinib in parent study and continue to benefit from the treatment. Participants will be monitored for side effects and overall health to better understand the effects of long-term treatment and support future care for adults with GIST.
Epistemonikos ID: 257dd29f6cbdbc91238e1252fe4e4c31c4fc8ff6
First added on: Sep 29, 2026